A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
- Status
- UNKNOWN
- Phase
- N/A
Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Second-line Chemotherapy in Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers of Bone Resorption in Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC
- Status
- COMPLETED
- Phase
- N/A
Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Blood From Patients With Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
Phase II Sunitinib Prog Met AIPC
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2